Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
An Acad Bras Cienc ; 91(3): e20181330, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31508665

RESUMEN

Type 1 diabetes (T1D) is the result of the selective destruction of the pancreatic ß-cells by T cells of the immune system. Although spleen is a secondary lymphoid organ, it is also involved in the T1D pathogenesis. However, the alterations in a variety of cellular processes of this disease need to be further understood. We aimed to analyze the benefits of resveratrol, and its complexed form on diabetic complications in the spleen of rats. To this end, we investigated important enzymes of phosphoryl transfer network, and Na+, K+-ATPase activity. Wistar rats were divided into non-diabetic groups: Control, Ethanol, Resveratrol, Hydroxypropyl-ß-cyclodextrin, Resveratrol-hydroxypropyl-ß-cyclodextrin, and diabetic groups with the same treatments. Diabetes was induced by a single dose of 60 mg/kg of streptozocin intraperitoneally, and treatments by intragastric gavage once daily for 60 days. Hyperglycemia reduced creatine kinase activity, which was reversed by the administration of resveratrol. Na+, K+-ATPase activity was greatly affected, but it was reversed by resveratrol and resveratrol-hydroxypropyl-ß-cyclodextrin. This suggest an energetic imbalance in the spleen of diabetic rats, and in case this also occurs in the diabetic patients, it is possible that resveratrol supplementation could be beneficial to the better functioning of the spleen in diabetic patients.


Asunto(s)
2-Hidroxipropil-beta-Ciclodextrina/farmacología , Antioxidantes/farmacología , Diabetes Mellitus Experimental/metabolismo , Resveratrol/farmacología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Bazo/metabolismo , Animales , Antioxidantes/metabolismo , Glucemia/análisis , Peso Corporal , Creatina Quinasa/metabolismo , Diabetes Mellitus Experimental/inducido químicamente , Metabolismo Energético/efectos de los fármacos , Hiperglucemia/metabolismo , Masculino , Tamaño de los Órganos , Ratas , Ratas Wistar , Estreptozocina
2.
Exp Parasitol ; 169: 51-8, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27472985

RESUMEN

The aim of this study was to evaluate the effect of subcutaneous administration of diphenyl diselenide (PhSe)2 on animal behavior and activities of acetylcholinesterase (AChE), adenylate kinase (AK), and creatine kinase (CK) in the brain of mice infected by Toxoplasma gondii. In addition, thiobarbituric acid reactive species (TBARS) levels and glutathione (GR, GPx and GST) activity were also evaluated. For the study, 40 female mice were divided into four groups of 10 animals each: group A (uninfected and untreated), group B (uninfected and treated with (PhSe)2), group C (infected and untreated) and group D (infected and treated with (PhSe)2). The mice were inoculated with 50 cysts of the ME49 strain of T. gondii. After infection the animals of the groups B and D were treated on days 1 and 20 post-infection (PI) with 5.0 µmol/kg of (PhSe)2 subcutaneously. Behavioral tests were conducted on days 29 PI to assess memory loss (object recognition), anxiety (elevated plus maze), locomotor and exploratory activity (Open Field) and it was found out that infected and untreated animals (group C) had developed anxiety and memory impairment, and the (PhSe)2 treatment did not reverse these behavioral changes on infected animals treated with (PhSe)2 (group D). The results showed an increase on AChE activity (P < 0.01) in the brain of infected and untreated animals (group C) compared to the uninfected and untreated animals (group A). The AK and CK activities decreased in infected and untreated animals (group C) compared to the uninfected and untreated animals (group A) (P < 0.01), however the (PhSe)2 treatment did not reverse these alterations. Infected and untreated animals (group C) showed increased TBARS levels and GR activity, and decreased GPx and GST activities when compared to uninfected and untreated animals (group A). Infected animals treated with (PhSe)2 (group D) decreased TBARS levels and GR activity, while increased GST activity when compared to infected and untreated animals (group C). It was concluded that (PhSe)2 showed antioxidant activity, but the dose used had no anti-inflammatory effect and failed to reverse the behavioral changes caused by the parasite.


Asunto(s)
Conducta Animal/efectos de los fármacos , Derivados del Benceno/uso terapéutico , Encéfalo/efectos de los fármacos , Compuestos de Organoselenio/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Toxoplasmosis Animal/tratamiento farmacológico , Acetilcolinesterasa/metabolismo , Adenilato Quinasa/metabolismo , Animales , Derivados del Benceno/administración & dosificación , Derivados del Benceno/farmacología , Encéfalo/enzimología , Encéfalo/patología , Creatina Quinasa/metabolismo , Femenino , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Inyecciones Subcutáneas , Ratones , Compuestos de Organoselenio/administración & dosificación , Compuestos de Organoselenio/farmacología , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Toxoplasmosis Animal/fisiopatología
3.
Pathol Res Pract ; 210(12): 1068-74, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25017420

RESUMEN

The aim of this study was to evaluate the effects of treatment with free and nanoencapsulated essential oil of Achyrocline satureioides on trypanosomosis and its oxidative/antioxidants variables in liver and kidney of rats infected experimentally with Trypanosoma evansi. For that, 48 rats were divided into six groups (A-F), eight animals each group. Groups A, C and D were composed of uninfected animals, while animals in groups B, E and F were inoculated intraperitoneally with T. evansi. Groups A and B were used as controls, negative and positive, respectively. Groups C and E receive oil (orally), as well as the animals in groups D and F were treated with nanoencapsulated essential oil. The treatment was not able to eliminate the parasites, but it remained the levels of parasitemia low. The carbonyl levels in liver and kidney did not differ between groups. Infected animals (group B) showed an increase in the TBARS levels and a decrease in the CAT activity and NPSH levels in liver and kidney, compared with the same parameters in the control (group A). Treatment with A. satureioides (groups C and D) did not influence the TBARS levels and CAT activity in the liver, but it increased the CAT activity in kidneys of the animals of group C. NPSH levels decreased in liver in the groups treated with nanoencapsulated essential oil (groups D and F). An interesting result observed was that the animals infected and then treated with essential oil of A. satureioides (groups E and F) did not differ from animals of group A for TBARS, CAT and NPSH, unlike what happened with the animals of group B. Therefore, the treatment with essential oil did not eliminate the parasites from the bloodstream, but it reduced the number of trypanosomes, mainly by its nanoencapsulated form. The same occurred with the lipid peroxidation in the liver. However, the treatments reduced the oxidative damage, and it led to the activation of the antioxidant enzymes. We believe that the association of this natural product with a trypanocidal drug may enhance its curative effect.


Asunto(s)
Achyrocline/química , Aceites Volátiles/farmacología , Parasitemia/tratamiento farmacológico , Fitoterapia , Preparaciones de Plantas/uso terapéutico , Trypanosoma , Animales , Antioxidantes/farmacología , Femenino , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Fitoterapia/métodos , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
4.
Exp Parasitol ; 134(3): 356-61, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23562884

RESUMEN

The aim of this study was to investigate the susceptibility in vitro of Trypanosoma evansi to the essential oils of andiroba (Carapa guaianensis) and aroeira (Schinus molle), in their conventional and nanostructured forms. For that, pure oils at concentrations of 0.5%, 1.0% and 2.0% were used. A negative control (untreated) and a positive control (diminazene aceturate 0.5%) were used as comparative parameters. Later, the same tests were performed, using nanoemulsions oils at concentrations of 0.5% and 1.0%. The tests were carried out in triplicates and the numbers of parasites were quantified on 1, 3 and 6 h from onset of the study. A dose-dependent reduction in the number of parasites to the forms of two oils tested was observed after 1 h. The concentration of parasites was significantly reduced at low concentrations after 3 h, as well as at 6 h no alive parasites were observed for the essential oils tested. Ours findings indicate, for the first time, that oils of andiroba and aroeira (in their conventional and nanoemulsion forms) have high activity against T. evansi in vitro, leading to the suggestion that these oils may be applied as an alternative treatment for this disease.


Asunto(s)
Anacardiaceae/química , Meliaceae/química , Aceites Volátiles/farmacología , Tripanocidas/farmacología , Trypanosoma/efectos de los fármacos , Animales , Bioensayo , Medios de Cultivo , Diminazeno/análogos & derivados , Diminazeno/farmacología , Relación Dosis-Respuesta a Droga , Emulsiones , Concentración de Iones de Hidrógeno , Ratones , Nanoestructuras , Aceites Volátiles/química , Concentración Osmolar , Extractos Vegetales/farmacología , Tripanocidas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA